Insider · CIK 0001495411

Goldan Keith A.

CIK 0001495411 Name as filed on the most recent filing

Filed as Goldan Keith A. (15)

15 transaction lines · from 15 filings · filed 2015-08-11 to 2026-06-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

15 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-06-01 S, Open-market sale Syndax Pharmaceuticals IncSNDX 22,351, disposed Open Form 4 filing 0001193125-26-253603
2026-02-09 S, Open-market sale Syndax Pharmaceuticals IncSNDX 71,705, disposed Open Form 4 filing 0001193125-26-043813
2026-02-06 S, Open-market sale Syndax Pharmaceuticals IncSNDX 42,931, disposed Open Form 4 filing 0001193125-26-041497
2025-07-16 S, Open-market sale Syndax Pharmaceuticals IncSNDX 12,033, disposed Open Form 4 filing 0000950170-25-096948
2025-05-19 P, Open-market purchase Syndax Pharmaceuticals IncSNDX Not reported Open Form 4 filing 0000950170-25-074304
2025-02-10 S, Open-market sale Syndax Pharmaceuticals IncSNDX 58,559, disposed Open Form 4 filing 0000950170-25-019005
2024-06-14 P, Open-market purchase Syndax Pharmaceuticals IncSNDX 25,037, acquired Open Form 4 filing 0001562180-24-005118
2023-06-13 S, Open-market sale Syndax Pharmaceuticals IncSNDX 12,873, disposed Open Form 4 filing 0001562180-23-005152
2022-03-16 S, Open-market sale OptiNose, Inc.OPTN 9,742, disposed Open Form 4 filing 0001494650-22-000029
2021-12-16 S, Open-market sale OptiNose, Inc.OPTN 951, disposed Open Form 4 filing 0001494650-21-000155
2021-09-16 S, Open-market sale OptiNose, Inc.OPTN 1,612, disposed Open Form 4 filing 0001494650-21-000108
2021-06-17 S, Open-market sale OptiNose, Inc.OPTN 2,148, disposed Open Form 4 filing 0001494650-21-000076
2021-03-15 S, Open-market sale OptiNose, Inc.OPTN 9,032, disposed Open Form 4 filing 0001494650-21-000041
2020-09-23 P, Open-market purchase OptiNose, Inc.OPTN 9,743, acquired Open Form 4 filing 0001494650-20-000125
2015-08-11 P, Open-market purchase Fibrocell Science, Inc.FCSC 12,660, acquired Open Form 4 filing 0000357097-15-000092

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 4
  • Open-market sale 11
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Goldan Keith A., insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001495411

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.